G. Wilkinson
Impact in
- Pharmacology top 0.01%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Inorganic Chemistry top 0.05%
- Asymmetric Hydrogenation and Catalysis
Papers in
-
- Organometallic Complex Synthesis and Catalysis 94
- Inorganic and Organometallic Chemistry 31
-
- Asymmetric Hydrogenation and Catalysis 47
- Co-authors
- David G. Shand (12 shared papers)Richard B. Kim (24 shared papers)John A. Osborn (16 shared papers)T. A. STEPHENSON (5 shared papers)Robert A. Branch (32 shared papers)John Birmingham (8 shared papers)T. S. Piper (8 shared papers)Kenneth E. Thummel (4 shared papers)
- Journals
- Clinical Pharmacology & Therapeutics (54 papers)Journal of the American Chemical Society (19 papers)Journal of Pharmacology and Experimental Therapeutics (11 papers)Inorganic Chemistry (7 papers)Nature (5 papers)
- Partner nations
- United StatesUnited KingdomJapan
In The Last Decade
G. Wilkinson
399 papers receiving 33.1k citations
G. Wilkinson's Hit Papers
Peers
Comparison fields: 5 of 186
- Pharmacology 8.4k
- Inorganic Chemistry 7.0k
- Process Chemistry and Technology 1.4k
- Organic Chemistry 11.0k
- Oncology 8.6k
Countries citing papers authored by G. Wilkinson
This map shows the geographic impact of G. Wilkinson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Wilkinson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Wilkinson more than expected).
Fields of papers citing papers by G. Wilkinson
This network shows the impact of papers produced by G. Wilkinson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Wilkinson. The network helps show where G. Wilkinson may publish in the future.
Co-authors
The 25 scholars most cited alongside G. Wilkinson, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 404 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | A physiological approach to hepatic drug clearance Hit paper breakdown → | 1975 | 1542 |
| 2 | The preparation and properties of tris(triphenylphosphine)halogenorhodium(I) and some reactions thereof including catalytic homogeneous hydrogenation of olefins and acetylenes and their derivatives Hit paper breakdown → | 1966 | 1138 |
| 3 | The drug transporter P-glycoprotein limits oral absorption and brain entry of HIV-1 protease inhibitors. Hit paper breakdown → | 1998 | 910 |
| 4 | Drug Metabolism and Variability among Patients in Drug Response Hit paper breakdown → | 2005 | 833 |
| 5 | Lorazepam Is an Independent Risk Factor for Transitioning to Delirium in Intensive Care Unit Patients Hit paper breakdown → | 2005 | 813 |
| 6 | The major genetic defect responsible for the polymorphism of S-mephenytoin metabolism in humans. Hit paper breakdown → | 1994 | 793 |
| 7 | IN VITRO AND IN VIVO DRUG INTERACTIONS INVOLVING HUMAN CYP3A Hit paper breakdown → | 1998 | 704 |
| 8 | New complexes of ruthenium (II) and (III) with triphenylphosphine, triphenylarsine, trichlorostannate, pyridine and other ligands Hit paper breakdown → | 1966 | 681 |
| 9 | Identification of a new genetic defect responsible for the polymorphism of (S)-mephenytoin metabolism in Japanese. Hit paper breakdown → | 1994 | 649 |
| 10 | Dichlorotetrakis(dimethyl sulphoxide)ruthenium(II) and its use as a source material for some new ruthenium(II) complexes Hit paper breakdown → | 1973 | 632 |
| 11 | Alkyl and aryl derivatives of π-cyclopentadienyl compounds of chromium, molybdenum, tungsten, and iron Hit paper breakdown → | 1956 | 612 |
| 12 | Hydroformylation of alkenes by use of rhodium complex catalysts Hit paper breakdown → | 1968 | 523 |
| 13 | The effects of age and liver disease on the disposition and elimination of diazepam in adult man. Hit paper breakdown → | 1975 | 522 |
| 14 | Oral first-pass elimination of midazolam involves both gastrointestinal and hepatic CYP3A-mediated metabolism* Hit paper breakdown → | 1996 | 509 |
| 15 | OATP and P-Glycoprotein Transporters Mediate the Cellular Uptake and Excretion of Fexofenadine Hit paper breakdown → | 1999 | 500 |
| 16 | Pharmacogenetics of efavirenz and central nervous system side effects: an Adult AIDS Clinical Trials Group study. | 2004 | 479 |
| 17 | 1999 | 397 | |
| 18 | 667. Carboxylates of palladium, platinum, and rhodium, and their adducts Hit paper breakdown → | 1965 | 391 |
| 19 | Bis-cyclopentadienyl Compounds of Ti, Zr, V, Nb and Ta Hit paper breakdown → | 1954 | 379 |
| 20 | 1985 | 371 |
About G. Wilkinson
G. Wilkinson is a scholar working on Organic Chemistry, Inorganic Chemistry, Pharmacology, Oncology and Materials Chemistry, having authored 404 papers that have together received 35.4k indexed citations. Recurring topics across this work include Organometallic Complex Synthesis and Catalysis (94 papers), Pharmacogenetics and Drug Metabolism (71 papers), Asymmetric Hydrogenation and Catalysis (47 papers), Drug Transport and Resistance Mechanisms (41 papers), Metal complexes synthesis and properties (38 papers), Inorganic and Organometallic Chemistry (31 papers), Magnetism in coordination complexes (26 papers) and Chemical Synthesis and Analysis (26 papers). The work is most often cited by research in Pharmacology (8.4k citations), Inorganic Chemistry (7.0k citations), Process Chemistry and Technology (1.4k citations), Organic Chemistry (11.0k citations) and Oncology (8.6k citations). G. Wilkinson has collaborated with scholars based in United States, United Kingdom and Japan. Frequent co-authors include David G. Shand, Richard B. Kim, John A. Osborn, T. A. STEPHENSON, Robert A. Branch, John Birmingham, T. S. Piper, Kenneth E. Thummel, F. H. Jardine and J.F. Young. Their work appears in journals such as Clinical Pharmacology & Therapeutics, Journal of the American Chemical Society, Journal of Pharmacology and Experimental Therapeutics, Inorganic Chemistry and Nature.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.